Evidence map›Paper›PMID 29300052›Full record

ArticleNature materials2018

Exploiting the pliability and lateral mobility of Pickering emulsion for enhanced vaccination.

Yufei Xia, Jie Wu, Wei Wei, Yiqun Du, Tao Wan, Xiaowei Ma, Wenqi An, Aiying Guo, Chunyu Miao, Hua Yue and 4 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature materials, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 262 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Preparation and mechanism study ofFrontiers in immunology · 2026
    Article
  6. Immunostimulatory Pickering emulsion for oral vaccine delivery.International journal of pharmaceutics · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules.Handbook of experimental pharmacology · 2024
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Yufei XiaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.ORCID 0000-0003-1215-6128
Jie WuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Wei WeiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Yiqun DuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Tao WanState Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, PR China.
Xiaowei MaHualan Biological Bacterin Co., Ltd, Xinxiang 453003, PR China.
Wenqi AnHualan Biological Bacterin Co., Ltd, Xinxiang 453003, PR China.
Aiying GuoHualan Biological Bacterin Co., Ltd, Xinxiang 453003, PR China.
Chunyu MiaoState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Hua YueState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Shuoguo LiCenter for Biological Imaging, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, PR China.
Xuetao CaoState Key Laboratory of Medical Immunology & Institute of Immunology, Second Military Medical University, Shanghai 200433, PR China.
Zhiguo SuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Guanghui MaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, PR China.
Institute of Process Engineering · CNHenan Institute of Technology · CNSecond Military Medical University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major challenge in vaccine formulations is the stimulation of both the humoral and cellular immune response for well-defined antigens with high efficacy and safety. Adjuvant research has focused on developing particulate carriers to model the sizes, shapes and compositions of microbes or diseased cells, but not antigen fluidity and pliability. Here, we develop Pickering emulsions-that is, particle-stabilized emulsions that retain the force-dependent deformability and lateral mobility of presented antigens while displaying high biosafety and antigen-loading capabilities. Compared with solid particles and conventional surfactant-stabilized emulsions, the optimized Pickering emulsions enhance the recruitment, antigen uptake and activation of antigen-presenting cells, potently stimulating both humoral and cellular adaptive responses, and thus increasing the survival of mice upon lethal challenge. The pliability and lateral mobility of antigen-loaded Pickering emulsions may provide a facile, effective, safe and broadly applicable strategy to enhance adaptive immunity against infections and diseases.

Indexed as

Adaptive ImmunityAdjuvants, ImmunologicAntigensDrug CarriersSurface-Active AgentsAnimalsAntigen-Presenting CellsCell SurvivalEmulsionsMiceAdjuvants, ImmunologicAntigensDrug CarriersEmulsionsSurface-Active Agents

Identifiers

PMID29300052
OpenAlexW2782472870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.